LOURDES SANCHEZ: Open Payments
NPI 1174188700 · HOLLYWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,727 in 87 payments from 22 companies in 2025. Trend: 2023 $1,806 · 2024 $1,895 · 2025 $1,727
Food & beverage: $1,727
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $235 |
| ABBVIE INC. | 17 | $229 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $168 |
| Gilead Sciences, Inc. | 6 | $152 |
| Amgen Inc. | 10 | $140 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $130 |
| Lilly USA, LLC | 5 | $90 |
| PFIZER INC. | 4 | $81 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $81 |
| ViiV Healthcare Company | 2 | $52 |
Products named: AIRSUPRA, CAPLYTA, VRAYLAR, OTEZLA, JARDIANCE, Kerendia, MOUNJARO, UBRELVY.
Industry payments across FL — which companies pay providers there.
